Pulmonary hypertension from any cause significantly increases the risk of perioperative morbidity and mortality. Of the respiratory disorders that can cause pulmonary hypertension, chronic obstructive pulmonary disease (COPD) is the most common 1 . The elevation in pulmonary artery pressure tends to be mild in patients with clinically stable COPD. Severe pulmonary arterial hypertension is uncommon in the setting of COPD 2 . Pulmonary arterial hypertension progresses slowly in patients with COPD and its presence confers a poor prognosis 3 . The development of cor pulmonale and presence of an intracardiac right-to-left shunt further complicates management and increases the risks of perioperative complications. We report on the management of such a case of advanced bronchiectasis with pulmonary hypertension, cor pulmonale and presence of a right-to-left shunt presenting for abdominal surgery.
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CASE HISTORY
A 54-year-old male weighing 50 kg was scheduled for sigmoid colectomy. He had advanced bronchiectasis on regular follow-up for fifteen years. His first presentation was for chest infection. A chest radiograph taken then showed bilateral bronchiectatic changes with multiple abscesses. Since then he had had numerous acute admissions related to his COPD, which responded to aggressive medical therapy. Seven months prior to the colectomy, he was admitted for congestive cardiac failure (CCF) diagnosed as secondary to cor pulmonale. He subsequently had another six admissions prior to the operation with three episodes of CCF. Two dimensional echocardiography showed mild mitral and severe tricuspid regurgitation. There was left and right ventricular systolic dysfunction, and the right ventricle was dilated. Ejection fraction was estimated to be 15%. There was moderately severe pulmonary hypertension and a patent foramen ovale (PFO) of 6 mm diameter with right-to-left shunting of blood seen. During the last admission for acute dyspnoea, he also complained of bleeding per rectum. A flexible colonoscopy revealed an adenocarcinoma at the rectosigmoid junction.
Physical examination at the preoperative visit revealed a cyanosed and orthopnoeic patient. His jugular venous pulse was raised. The apex of the heart was displaced laterally in the sixth intercostal space. A moderately loud pansystolic murmur was heard at the lower sternal edge and diffuse bilateral coarse crepitations on auscultation of the chest. The chest radiograph showed cardiomegaly with prominent pulmonary arteries and oligaemic lung fields with bilateral bronchiectatic changes. The electrocardiogram showed a right bundle branch block pattern, presence of P pulmonale and atrial ectopics. Arterial blood gas analysis revealed a pH of 7.45, P a O 2 of 49.1 mmHg, P a CO 2 of 55.9 mmHg, bicarbonate of 35.5 mmol/l and SaO 2 of 85.7% with the subject breathing room air. The haemoglobin level was 139 g/l.
The patient was administered nebulized salbutamol and ipratropium one hour preoperatively. Continuous pulse oximetry and electrocardiography was established on arrival in the operating room. His SpO 2 breathing room air was 76%. He was sedated with 1 mg of intravenous midazolam before insertion of a central venous catheter in the right internal jugular vein and invasive arterial blood pressure (BP) monitoring established via the right radial artery. Anaesthesia was induced using intravenous fentanyl 50 µg and ketamine 40 mg with tracheal intubation facilitated by rocuronium 30 mg. The patient was ventilated using an air-oxygen mixture with FiO 2 of 0.5. Midazolam 5 mg, titrated to haemodynamics, was administered intravenously pre-incision and an infusion of 1.5 mg/hr maintained throughout the operation. Further boluses of fentanyl were given to a total of 400 µg over two hours of surgery. Relaxation was maintained with an infusion of rocuronium at 0.3 mg/kg/h. An infusion of adrenaline at 0.05 µg/kg/min was started just before induction and maintained into the postoperative period. Additionally, an infusion of noradrenaline started at induction was titrated against haemodynamic response to maintain the BP equal to or higher than the starting BP of 110/ 50 mmHg. The infusion was maintained at between 0.03-0.04 µg/kg/min throughout the operation. There appeared to be a good correlation between systemic BP and oxygen saturation, so that a systolic BP above 120 mmHg maintained the SpO 2 above 95%. The systolic BP intraoperatively ranged between a low of 100 mmHg just after induction to a high of 150 mmHg. The heart rate remained within the range of 95 to 105 beats per minute. The minute ventilation was adjusted to maintain an end-tidal CO 2 (EtCO 2 ) similar to the preoperative P a CO 2 value. Peak airway pressures were monitored closely during careful hand ventilation, while during mechanical ventilation gas flows and ventilatory parameters were adjusted to prevent excessively high airway pressures. Peak airway pressure while on the ventilator varied between 27 and 29 cmH 2 O. The EtCO 2 post induction was 58 mmHg and ventilation was adjusted to bring it to around 50 mmHg. Antibiotic prophylaxis was given at induction. Surgery was performed through a lower abdominal mid-line incision and the entire operation took about two hours. All the infusions were maintained until the end of surgery. Surgery was relatively uneventful with blood loss estimated to be 400 ml. Crystalloid to 1500 ml total was infused with a urine output of 250 ml intraoperatively.
On completion of surgery, the patient was transferred to the Intensive Care Unit (ICU) still intubated, for continuation of ventilatory support. The infusions of rocuronium and midazolam were stopped in the ICU and motor power allowed to recover spontaneously. The patient was fully conscious three hours later with good return of muscle power. An infusion of fentanyl was started at 20 µg/h and titrated to analgesic requirement. He was weaned off ventilatory support and extubated six hours post operation, fairly comfortable and haemodynamically stable. The noradrenaline and adrenaline infusions were tailed off and, after an uneventful course, he was discharged from the ICU on the third postoperative day.
DISCUSSION
There is little data available on the perioperative management, risks and outcome in patients with cor pulmonale and pulmonary hypertension due to advanced bronchiectasis. A search of the Medline database using the terms "anaesthesia" AND "cor pulmonale", "anaesthesia" AND "bronchiectasis", "anaesthesia" AND "pulmonary hypertension" and "anaesthesia" AND "Eisenmenger" made from 1966 to the present resulted in slightly over 300 articles, with none of the articles specifically dealing with this patient's combination of a right-to-left shunt in the presence of pulmonary hypertension and cor pulmonale resulting from advanced bronchiectasis.
In the absence of information specific to this patient, most of the relevant information relates to the Eisenmenger syndrome 4 . In common with this patient, there is a right-to-left shunt and the presence of pulmonary hypertension. The term Eisenmenger syndrome is used to describe reversal of the usual left-to-right shunt resulting from any systemic to pulmonary circulation connection, either intracardiac or via an aortopulmonary communication, due to severe pulmonary hypertension 5 . The right-to-left shunt in this patient was at atrial level via a patent foramen ovale due to increased right atrial pressure secondary to right heart failure and tricuspid regurgitation secondary to pulmonary hypertension due to bronchiectasis. A cause of secondary pulmonary hypertension is chronic obstructive or interstitial lung disease associated with the destruction of lung parenchyma and hence fewer alveolar capillaries. This causes increased pulmonary arterial resistance and secondarily, pressure 6 . Contributory causes include pulmonary vasoconstriction caused by alveolar hypoxia, acidaemia and hypercarbia as well as increased cardiac output and blood viscosity from polycythaemia secondary to hypoxia 1, 7 . The diagnosis of pulmonary hypertension is based on clinical and radiographic evidence as well as echocardiography 8 . Cardiac catheterization remains the gold standard, enabling direct measurement of pulmonary arterial pressures. There are significant risks and cost issues associated with cardiac catheterization. From a practical perspective, the use of Doppler echocardiography in the nonpregnant patient is accepted for the diagnosis and management of pulmonary hypertension 9, 10, 11, 12 . This is done by calculation of a transtricuspid gradient from the maximum velocity of tricuspid regurgitation jets using a modified Bernoulli equation. Adding the transtricuspid gradient to an estimate of the mean right atrial pressure yielded predictions of right ventricular systolic pressures that correlated well with catheterization values 11 . The prevalence of PFO in patients with secondary causes of pulmonary hypertension has been reported to be 28% 13 . This prevalence is similar to that of the general population 14 . It has been suggested that the presence of a PFO is not clinically important in patients with pulmonary hypertension. In a study of patients with pulmonary hypertension, there was no significant difference in baseline haemodynamics, including cardiac output or exercise tolerance in patients with PFO, leading the authors to suggest that a PFO does not provide substantial right-to-left intracardiac shunting in such patients 13 . This is in contrast with our patient who demonstrated a functional right-to-left shunt via his PFO seen during echocardiography and evidenced by his arterial blood gas results. A reasonable conclusion would be that his pulmonary hypertension was severe enough to cause this right-to-left shunt. The magnitude of intracardiac right-to-left shunting can be assessed qualitatively as small, moderate or large but can not be quantitated precisely with echocardiography 15 . The contribution of pulmonary shunting to this patient's arterial hypoxia is also difficult to quantitate. Decrease in pulmonary shunting with positive pressure ventilation and increased FiO 2 may also have contributed to the improvement in oxygenation seen intraoperatively. The mode of death in Eisenmenger syndrome appears to be "sudden" and truly unexpected in about 30% of patients. Death may be due to pulmonary artery rupture, severe dehydration, massive subarachnoid haemorrhage and other unknown mechanisms. About 20% die of right-sided heart failure 16 . The long-term prognosis of patients with the Eisenmenger syndrome is substantially better than that of patients with other conditions associated with pulmonary hypertension 17 . The risk of mortality of non-cardiac surgery for Eisenmenger syndrome has been quoted to be about 19 to 30% 18, 19 . In view of his underlying severe bronchiectasis, this patient would definitely have higher perioperative risk compared to a patient whose primary condition is the Eisenmenger syndrome. With a history of frequent admissions for exacerbation of COPD and chest infections coupled with three episodes of CCF from cor pulmonale in the preceding six months, perioperative management was aimed at prevention of an exacerbation of his COPD and precipitation of CCF.
The resistance of the pulmonary and systemic circulation is usually quite similar in patients who have developed a right-to-left shunt. Any increase in the pulmonary vascular resistance (PVR) or a fall in the systemic vascular resistance (SVR) will increase the right-to-left shunt causing hypoxia. The underlying principle of the anaesthetic technique chosen involved avoiding a fall in systemic BP by maintaining both cardiac output and SVR. Care was taken to prevent occurrence of any bronchospastic crisis by avoidance of drugs that may have direct or indirect bronchoconstrictive effects due to release of active mediators such as histamine. We also used prophylactic bronchodilators and care was taken to handle the airway gently. Steps taken to prevent an increase in PVR included prevention of hypoxia, hypercarbia and excessively high airway pressures.
A pulmonary artery catheter was not used because of the low benefit-risk ratio in this patient 20 . Measurement of cardiac output by thermodilution in the presence of the shunt is of limited use. Pulmonary hypertension will decrease the accuracy of the pulmonary capillary pressure as a reflection of the left atrial pressure. It is difficult to correctly position the pulmonary artery catheter and also there is an increased risk of pulmonary artery rupture and pulmonary infarction in patients with pulmonary hyper-tension. Flotation of the catheter through the PFO following blood flow may be catastrophic. The patient was treated with nebulized bronchodilators preoperatively to prevent bronchospasm. In view of his history of frequent exacerbations in spite of being compliant with medical treatment, a low dose infusion of adrenaline was started and maintained throughout the operation. Adrenaline has a powerful bronchodilator action, most evident when bronchial muscle is contracted because of disease or in response to drugs or various autacoids. In such situations, adrenaline has a striking therapeutic effect as a physiological antagonist to substances that cause bronchoconstriction 21 . The infusion was maintained at a low dose to minimize tachycardia and subsequent increased oxygen consumption. Adrenaline was used in favour of a pure intravenous β-adrenergic agonist because the latter would cause peripheral vasodilatation, which would reduce the SVR, as well as cause excessive tachycardia 21 . The reduced SVR will worsen the right-to-left shunt, and together with tachycardia, precipitate hypoxia. Hypoxia by itself has been identified as a strong independent factor causing increased PVR, which will further worsen the shunt 7 . About 10% of an inhaled dose of β-adrenergic agonist via aerosol therapy actually enters the lungs 21 . It was felt that aerosol therapy via the anaesthetic circuit is even less reliable. Noradrenaline is a potent agonist at α receptors with relatively little action on β 2 receptors. The total peripheral resistance is raised, and both systolic and diastolic blood pressure (BP) are increased with cardiac output unchanged or decreased 21 . It was used in this case to maintain or raise the SVR. As evidenced, the combination of infusions of adrenaline and noradrenaline was able to maintain the systolic BP above 120 mmHg while enabling the patient to have SpO 2 above 95% on FiO 2 of 0.5 intraoperatively, compared with 76% on room air preoperatively, with minimal effect on the heart rate and absence of any bronchospastic event.
A slow and controlled induction with a combination of low-dose intravenous ketamine and fentanyl was used to minimize changes in the SVR. Both drugs have minimal myocardial depression at the doses used. Ketamine in a dose of 2 mg/kg has been shown to have no significant effect on either the systemic or pulmonary vascular resistance in intubated children with elevated pulmonary resistance 22 . It also has analgesic effects and causes bronchodilation. The use of inhalational agents was avoided as all of them decrease the SVR and cause myocardial depression 23 . Nitrous oxide was not used because of the dangers of paradoxical embolism in the setting of a functional right-to-left shunt. It also increases PVR especially in the presence of pre-existing pulmonary hypertension 24 . Various authors have used different vasoconstrictors to treat decreases in SVR at induction and in the perioperative period [25] [26] [27] . An infusion of noradrenaline was chosen because it is easily titratable and allows fast and accurate control of BP at the various stages of surgery. Anaesthesia was maintained with an infusion of midazolam after the initial dose of 5 mg to prevent awareness together with boluses of fentanyl. Midazolam causes anterograde amnesia and has been shown to decrease the incidence of awareness with recall 28 . It has also been shown that there is significant interindividual variability in bispectral index values (BIS) despite standardized dosages of fentanyl and there is no correlation between the BIS values and midazolam and fentanyl drug concentrations 29, 30 . The same study suggested that BIS is not an accurate measure of the depth of anaesthesia when using a combination of fentanyl and midazolam 30 . In the absence of a more reliable monitor, we elected to monitor for awareness by observation of clinical parameters. Both drugs do not have significant effects on systemic and pulmonary vascular resistance at the dosages used compared to inhalational anaesthetics at MAC values. For muscle relaxation, rocuronium was chosen for its rapid onset of action and lack of histamine release with the intubating dose. It has favourable pharmacokinetics for infusion and a predictable profile for recovery of muscle power 31 . Muscle paralysis was not reversed in order to avoid the possible side-effects of reversal agents. Recovery from the effects of midazolam and fentanyl is also unpredictable as intravenous fentanyl can decrease the systemic clearance of midazolam by 30% and increase the elimination half-time by 50% 32 . Care was taken throughout the operation to prevent accidental air embolism via the indwelling lines and strict asepsis maintained during the insertion of lines to prevent catheter-related sepsis causing endocarditis.
Our institution does not have facilities for the use of nitric oxide, which may have been useful in such a case though it may be of limited value in the treatment of acute exacerbations of COPD 33, 34 . There is a paucity of information with regard to the perioperative risks and optimal management of COPD patients with severe pulmonary hypertension presenting for major surgery. In spite of the high perioperative risks involved, a proper understanding of the underlying pathophysiology allows for selection of an appropriate anaesthetic technique. Careful use of drugs to maintain the balance between systemic and pulmonary vascular resistance, choice of anaesthetic drugs that had minimal side-effects on the compromised cardiorespiratory system, and meticulous attention to detail contributed to an uneventful outcome for this patient.
